Sepsis-associated Purpura fulminans in adults

Wiener Klinische Wochenschrift

Volumn 113, Issue 3-4, 2001, Pages 107-112

  Gamper, G ^a   Oschatz, E ^a   Herkner, H ^a   Paul, G ^a   Burgmann, H ^a   Janata, K ^a   Roggla M ^a   Laggner, A N ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Meningococcemia; Prognostic factors; Score; Sepsis associated purpura fulminans

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FULMINATING PURPURA; HOSPITAL ADMISSION; HUMAN; LABORATORY DIAGNOSIS; LACTIC ACIDOSIS; MALE; MENINGOCOCCEMIA; MORTALITY; MULTIPLE ORGAN FAILURE; PREDICTION; PROGNOSIS; SCORING SYSTEM; SEPSIS; SEPTICEMIA; SHOCK;

ADOLESCENT; ADULT; AGE FACTORS; APACHE; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEPSIS; TIME FACTORS; WATERHOUSE-FRIDERICHSEN SYNDROME;

EID: 0035864772     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hemostasis and thrombosis
2. Proposed classification and pathologic mechanism of sepsis-associated purpura fulminans and skin necrosis
3. Clinical aspects of consumptive thrombohemorrhagic disorders
4. Fatal overwhelming post-splenectomy infection
5. Lebensbedrohliche infektion nach splenektomie - Das "overwhelming post-splenectomy infection"-syndrom
6. Management of meningococcal infections
7. Risk factor for death in meningococcal disease
8. Prognostic factors in meningococcal disease
9. Prognosis of meningococcal septicaemia
10. APACHE II: A severity of disease classification system
11. An expanded definition of the adult respiratory syndrome
12. Memoire sur la maladie qui a regne a Geneve au printemps de 1805
13. A case of suprarenal apoplexy
14. Validation of the Glasgow meningococcal septicemia prognostic score. A 10 year retrospective survey
15. Prognostic evaluation in meningococcal disease. A retrospective study of 115 cases
16. Prognostic indicators of the outcome of meningococcal disease: A study of 562 patients
17. Predictors of outcome in acute meningococcal infection in children
18. Risk factor for death in meningococcal disease
19. Fulminante sepsis nach post-traumatischer splenektomie - Das OPSI syndrom
20. Septic shock, multiple organ failure, and disseminated intravascular coagulation
21. Adult overwhelming meningococcal purpura. A study of 35 cases, 1977-89
22. Disseminated intravascular coagulation
23. Disseminated intravascular coagulation. Objective criteria for diagnosis and management
24. Characterisation of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation
25. Use of protein-C concentrate, heparin and haemodiafiltration in meningococcus-induced sepsis-associated purpura fulminans
26. Protein C in the treatment of coagulopathy in meningococcal disease
27. Meningococcemia and purpura fulminas in adults: Acute deficiencies of protein C and S and early treatment with AT III concentrates
28. Recombinant tissue plaminogen activator restores perfusion in meningococcal sepsis-associated purpura fulminans
29. Thrombolytic therapy in adult meningococcal sepsis-associated purpura fulminans with acute renal failure and severe perfusion deficits to the extremities
30. Plasma and whole blood exchange in meningococcal sepsis
31. Meningococcal septicemia treated with combined plasmapheresis and leucapheresis or with blood exchange
32. Extracorporal support for intractable cardiorespiratory failure due to meningococcal disease
33. Penicillin insensitive neisseria meningitidis
34. Antibiotic choices beyond the neonatal period
35. Dexamethason in the treatment of acute bacterial meningitis: The effect of the study design in the interpretation of the results
36. Fulminant meningococcaemia: Heparin therapy and survival rate
37. Diagnosis and management of disseminated intravascular coagulation: The role of heparin therapy
38. A study of 42 episodes of overwhelming post-splenectomy infection: Is current guidance for asplenic individuals being followed?
39. Meningokokkenerkrankungen in österreich